Diagnostic Accuracy of Lung Ultrasound for Pneumonia Diagnosis in Children

NCT ID: NCT07331311

Last Updated: 2026-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

320 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-19

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chest X-ray is historically being used as an imaging standard to aid to the diagnosis of childhood pneumonia, however, the evidence does not support it as a perfect imaging tool. As an alternative to CXR, lung ultrasound (LUS) could be used as the imaging of choice in children and studies have demonstrated its good accuracy to diagnose childhood pneumonia. However, most diagnostic studies have used CXR as a reference standard.

In absence of a 'gold standard' approach, there is a risk that large proportion of children with pneumonia and severe pneumonia could be 'missed' if clinicians relied on LUS only.

This research aims to evaluate the diagnostic benefit of LUS in children compared against 'gold standard' diagnosis which is derived based on the clinical information, imaging and laboratory investigations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia Childhood Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Lung ultrasound followed by chest X-ray in all enrolled participants as chest imaging investigation
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Care provider performing LUS scans are masked of CXR report and clinical information about he participant, other than the case has WHO defined pneumonia

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chest imaging

Single arm study that evaluates the role of LUS in diagnosing pneumonia in children. All participants receive LUS scans followed by CXR as chest imaging intervention.

Group Type EXPERIMENTAL

LUS as a chest imaging tool

Intervention Type DIAGNOSTIC_TEST

Each study participant receives LUS scan followed by CXR as chest imaging modality. LUS is the diagnostic test under investigation, compared against clinical gold standard (described later).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LUS as a chest imaging tool

Each study participant receives LUS scan followed by CXR as chest imaging modality. LUS is the diagnostic test under investigation, compared against clinical gold standard (described later).

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical suspicion of pneumonia. Pneumonia is suspected in a child meeting the WHO case definition of pneumonia, i.e. cough or difficulty breathing associated with fast breathing and/ or lower chest wall indrawing.

Exclusion Criteria

* Non-consenting parents.
* Children who are hospitalized for more than 24 hours.
* Children treated for pneumonia at the study site within past 4 weeks.
* Critical patients requiring emergency lifesaving support and parents unable to cooperate to provide consent.
Minimum Eligible Age

2 Months

Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

London School of Hygiene and Tropical Medicine

OTHER

Sponsor Role collaborator

Global Health Research and Medical Interventions Institute (GlohMed), Nepal

UNKNOWN

Sponsor Role collaborator

Nagasaki University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Suraj BHATTARAI

Research fellow (WISE programme)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Suraj Bhattarai, MBBS, MSc, DTM&H

Role: PRINCIPAL_INVESTIGATOR

London School of Hygiene and Tropical Medicine/ Nagasaki University School of Tropical Medicine and Global Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Siddhi Memorial Hospital

Bhaktapur, Bagmati, Nepal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Nepal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

31322

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pediatric Bronchoscopy and LUS
NCT06658613 COMPLETED